Skip to main content

Animations

MJFF Publications

5021 - 5030 of 8785 Results
Title
Year
  • Year
  • 2016
  • 2022
  • 2021
  • 2022
  • 2016
  • 2020
  • 2014
  • 2018
  • 2019
  • 2022
  • Summary Details
    OPEN
    Title: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000044
    Citation Count: 35
  • Summary Details
    OPEN
    Title: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200008
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000557
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Genome Sequencing in the Parkinson Disease Clinic
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200002
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000193
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000711
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Course of psychiatric symptoms and global cognition in early Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801
    Citation Count: 118
  • Summary Details
    OPEN
    Title: Longitudinal analysis of impulse control disorders in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000005816
    Citation Count: 222
  • Summary Details
    OPEN
    Title: Unique white matter structural connectivity in early-stage drug-naive Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008867
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.